Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2018-06-01
2018-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Exercise on Fructose-induced Postprandial Lipemia
NCT03173495
Disposal of Oral Fructose During Exercise
NCT01128647
Fructose and Glucose and TAS1R2 in Type 1 Diabetes
NCT01713023
Effects of Exercise on Fructose Metabolism
NCT01866215
Meta-analyses of Fructose and Cardiometabolic Risk
NCT01363791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fructose-rich diet
Subjects will be submitted to a standard diet associated with a sweetened beverage (provided by the researchers) during 4 weeks. Without knowing the content (blind), they will receive fructose based beverage, prepared as a solution with 10% fructose, water and flavoring powder, totaling 1.0g / kg of body mass / day of fructose.
Fructose
Consumption of 1.0g / kg of body mass / day of fructose.
Glucose-rich diet
Subjects will be submitted to a standard diet associated with a sweetened beverage (provided by the researchers) during 4 weeks. Without knowing the content (blind), they will receive glucose based beverage, prepared as a solution with 10% glucose, water and flavoring powder, totaling 1.0g / kg of body mass / day of glucose.
Glucose
Consumption of 1.0g / kg of body mass / day of glucose.
Fructose-rich diet and exercise
The subjects will perform the same protocol described in the intervention Fructose-rich diet, except for the inclusion of the physical exercise. During the 4-week intervention, participants will perform three sessions a week of 60 minutes of aerobic exercise at 60% of VO2 peak on cycle ergometer.
Fructose and exercise
Consumption of 1.0g / kg of body mass / day of fructose + 3 weekly sessions of 60 minutes of aerobic exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fructose
Consumption of 1.0g / kg of body mass / day of fructose.
Glucose
Consumption of 1.0g / kg of body mass / day of glucose.
Fructose and exercise
Consumption of 1.0g / kg of body mass / day of fructose + 3 weekly sessions of 60 minutes of aerobic exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not engaged in regular exercises;
* Aged between 19 and 35 years;
* Body mass index (BMI) of less than 30kg / m².
Exclusion Criteria
* Smokers;
* Dyslipidemic;
* Diabetic;
* Hypertensive;
* Alcohol use;
* Appetite suppressants use;
* Medications use;
* Supplements use;
* Chronic disease that impedes the performance of physical exercise.
19 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Rio Grande do Sul
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alvaro Reischak-Oliveira
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
84642318.8.0000.5347
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.